Fig. 6From: Egyptian pediatric clinical practice adapted guidelines: evidence-based [2] steroid-resistant nephrotic syndrome (SRNS) 2022EPG management of C3G/DDD with membranoproliferative changes. R 3.2.2 FBack to article page